These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 15762225)

  • 1. Results of an electronic mail survey on hormones and telangiectasias.
    Ricci S
    Dermatol Surg; 2005 Feb; 31(2):246-8. PubMed ID: 15762225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sex steroid hormones and breast cancer: is there a link with oral contraceptives and hormone replacement therapy?
    Khoo SK; Chick P
    Med J Aust; 1992 Jan; 156(2):124-32. PubMed ID: 1736053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Estrogens and cardiovascular diseases: should current guidelines be changed?].
    Beller F; Theiss W
    Zentralbl Gynakol; 1994; 116(8):441-8. PubMed ID: 7941812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Should oral contraceptives and postmenopausal hormonal substitution be withdrawn prior to surgery? A questionnaire study in departments of surgery and gynecology].
    Wessel N; Gerner T; Grøgaard HK
    Tidsskr Nor Laegeforen; 1995 Mar; 115(8):935-7. PubMed ID: 7709381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral contraceptive use and hormone replacement therapy are associated with microalbuminuria.
    Monster TB; Janssen WM; de Jong PE; de Jong-van den Berg LT;
    Arch Intern Med; 2001 Sep; 161(16):2000-5. PubMed ID: 11525702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship of hormone use to cancer risk.
    Bernstein L; Ross RK; Henderson BE
    J Natl Cancer Inst Monogr; 1992; (12):137-47. PubMed ID: 1616798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Side-effects from oral contraceptives.
    Human L
    S Afr Med J; 1973 Aug; 47(32):1444. PubMed ID: 4725623
    [No Abstract]   [Full Text] [Related]  

  • 8. Cerebral arterial occlusive disease with telangiectasia associated with oral contraceptives.
    Okawara SH; Calkins RA
    Arch Neurol; 1973 Jul; 29(1):60-2. PubMed ID: 4711806
    [No Abstract]   [Full Text] [Related]  

  • 9. Oral contraceptives and low back pain. Attitudes among physicians, midwives and physiotherapists.
    Brynhildsen J; Ekblad S; Hammar M
    Acta Obstet Gynecol Scand; 1995 Oct; 74(9):714-7. PubMed ID: 7572106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance of the androgenicity of progestins in hormonal therapy in women.
    Linn ES
    Clin Ther; 1990; 12(5):447-55. PubMed ID: 2268868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hormones and cardiovascular diseases: oral contraceptives and hormonal replacement therapy: differential effects on coronary heart disease, deep venous thrombosis and stroke. The ESHRE Capri Workshop Group.
    Hum Reprod; 1998 Aug; 13(8):2325-33. PubMed ID: 9756321
    [No Abstract]   [Full Text] [Related]  

  • 12. More on oral contraceptives, drug interactions, herbal medicines, and hormone replacement therapy.
    Shader RI; Greenblatt DJ
    J Clin Psychopharmacol; 2000 Aug; 20(4):397-8. PubMed ID: 10917398
    [No Abstract]   [Full Text] [Related]  

  • 13. A study of estrogen and progesterone receptors in spider telangiectasias of the lower extremities.
    Sadick NS; Niedt GW
    J Dermatol Surg Oncol; 1990 Jul; 16(7):620-3. PubMed ID: 2193959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective study of exogenous hormones and risk of pulmonary embolism in women.
    Grodstein F; Stampfer MJ; Goldhaber SZ; Manson JE; Colditz GA; Speizer FE; Willett WC; Hennekens CH
    Lancet; 1996 Oct; 348(9033):983-7. PubMed ID: 8855854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concordant and discordant effects on cardiovascular risks exerted by oestrogen and progestogen in women using oral contraception and hormone replacement therapy. ESHRE Capri Workshop Group.
    Crosignani PG; La Vecchia C
    Hum Reprod Update; 1999; 5(6):681-7. PubMed ID: 10652978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [P-pills, hormonal substitution and surgery--yes, or no?].
    Maltau JM; Oian P
    Tidsskr Nor Laegeforen; 1995 Mar; 115(8):934. PubMed ID: 7709380
    [No Abstract]   [Full Text] [Related]  

  • 17. Contraception for the transitional years of women older than 40 years of age.
    Upton GV; Corbin A
    Clin Obstet Gynecol; 1992 Dec; 35(4):855-64. PubMed ID: 1451368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hormone replacement therapy use and plasma levels of sex hormones in the Norwegian Women and Cancer postgenome cohort - a cross-sectional analysis.
    Waaseth M; Bakken K; Dumeaux V; Olsen KS; Rylander C; Figenschau Y; Lund E
    BMC Womens Health; 2008 Jan; 8():1. PubMed ID: 18194511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IARC monographs program on carcinogenicity of combined hormonal contraceptives and menopausal therapy.
    Schneider HP; Mueck AO; Kuhl H
    Climacteric; 2005 Dec; 8(4):311-6. PubMed ID: 16390765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term postmenopausal hormone therapy and endometrial cancer risk: a study by Doherty et al.
    Odem RR; Moniz MH; Allsworth JE; Bleckman CR; Omicioli VA; Lawrence LT; Thaker PH
    Am J Obstet Gynecol; 2007 Aug; 197(2):213-4; discussion e1-5. PubMed ID: 17689656
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.